基线18F-FDG PET/CT参数联合AI胸腔积液分割模型对恶性胸腔积液的预后意义
该研究纳入146例肺癌伴恶性胸腔积液患者,利用AI分割模型在基线18F-FDG PET/CT上提取参数,评估其对总生存的预后价值。SUVmax、MTV和TLG为关键生存预测因子,联合参数对12个月生存预测的AUC为0.849,优于LENT评分(AUC 0.732),内部验证AUC 0.840且校准良好。
要点
- AI分割模型可自动提取恶性胸腔积液的PET/CT代谢参数。
- SUVmax、MTV和TLG是独立的12个月生存预测因子。
- 联合PET/CT参数预测12个月生存优于LENT评分。
核心结论
- 基于深度学习的基线18F-FDG PET/CT参数在预测恶性胸腔积液患者生存方面表现优异,可能补充现有生存模型并指导分层治疗。
研究设计与样本
- 回顾性研究纳入146例肺癌伴恶性胸腔积液患者,采用结合3D空间加权和2D经典U-Net的AI分割模型提取PET/CT参数,以Cox回归分析12个月生存独立预测因子,用AUC和DeLong检验评估判别能力,Bootstrap重采样进行内部验证。
诊断标准与关键数值
- 联合PET/CT参数预测12个月生存的AUC为0.849(95%CI 0.795-0.903),优于LENT评分的AUC 0.732(95%CI 0.660-0.796)。
- 内部Bootstrap验证AUC为0.840(95%CI 0.671-0.922),校准曲线拟合良好。
- 关键生存预测因子包括SUVmax、MTV和TLG。
临床应用与阅片要点
- 在肺癌伴恶性胸腔积液患者的基线PET/CT报告中,可关注AI分割提取的SUVmax、MTV和TLG,辅助预后分层。
- 联合PET/CT代谢参数较LENT评分能更好识别12个月生存高风险患者,可能指导临床治疗强度选择。
局限性
- 样本量有限(146例),仅采用内部Bootstrap验证,缺乏外部验证。
- 回顾性研究设计可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: We aimed to use an artificial intelligence (AI)-based pleural effusion segmentation model on baseline 18F-FDG PET/CT images to investigate the prognostic value of PET/CT-derived parameters for overall survival (OS) among lung cancer patients with malignant pleural effusion (MPE).
METHODS: A total of 146 patients with MPEs were recruited. An integrated AI segmentation model combining 3D spatially weighted and 2D classical U-Net segmented pleural effusion for 18F-FDG PET/CT parameter extraction. Cox regression analyses revealed independent 12-month survival predictors. The area under the receiver operating characteristic curve (AUC) and DeLong's test were used to evaluate the discriminant power of the predictors and the LENT score. Bootstrap resampling was employed for internal validation.
RESULTS: The patients comprised 81 males (55.5%) and had a mean age of 61.7 (SD = 11.5) years. The key survival predictors included maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG). The combined PET/CT parameters demonstrated a statistically significant advantage over the LENT score for 12-month survival prediction (AUC: 0.849, 95% CI, 0.795-0.903 vs AUC: 0.732, 95% CI, 0.660-0.796). The internal bootstrap validation had an AUC of 0.840, (95% CI, 0.671-0.922) and demonstrated a well-fitting calibration curve.
CONCLUSIONS: The baseline 18F-FDG-PET/CT parameters extracted using the deep learning model performed excellently in predicting MPE survival and may complement existing MPE survival models and guide clinical stratified treatment.
ADVANCES IN KNOWLEDGE: AI-integrated 18F-FDG-PET/CT radiomics improved prognostic assessment of MPE, facilitating personalized interventions stratified by survival expectations.
引用
- Cao Y, Hu F, Feng S, et al. Prognostic significance of baseline 18F-FDG PET/CT parameters in combination with an artificial intelligence-based pleural effusion segmentation model for malignant pleural effusion. Br J Radiol. 2026. PMID: 42162960. doi:10.1093/bjr/tqag116
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。